[Which thrombolytic agents as therapy in acute myocardial infarct?].
Strauer
B E
BE
Medizinische Klinik, Heinrich-Heine-Universität Düsseldorf.
D000208:Acute Disease; D016255:Anistreplase / Q000627:therapeutic use; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy*; D013300:Streptokinase / Q000627:therapeutic use; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use
D005343:Fibrinolytic Agents; D016255:Anistreplase; D013300:Streptokinase; D010959:Tissue Plasminogen Activator; D014568:Urokinase-Type Plasminogen Activator
Welche Thrombolytika zur Therapie des akuten Myokardinfarktes?